<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News for Canada-based  companies .</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 07 Jan 2009 14:27:49 +0100</pubDate>
		<lastBuildDate>Wed, 07 Jan 2009 14:27:49 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Vasogen (VSGN) Provides Corporate Update; Explores Sale of Company, Merger or Acquisition</title>
			<link>http://www.lifescience-online.com/Vasogen__VSGN__Provides_Corporate_Update__Explores,13639.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/1/1.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Industry and Sector</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/vasogen,1215.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>VASOGEN INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 05 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>YM BIOSCIENCES&#039; NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE</title>
			<link>http://www.lifescience-online.com/YM_BIOSCIENCES__NIMOTUZUMAB_SELECTED_FOR_MULTINATI,13624.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/ym_biosciences,5503.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>YM BIOSCIENCES INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/NIMOTUZUMAB,8387.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NIMOTUZUMAB</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER</title>
			<link>http://www.lifescience-online.com/YM_BIOSCIENCES_RECEIVES_CLEARANCE_TO_INITIATE_RAND,13625.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/ym_biosciences,5503.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>YM BIOSCIENCES INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/NIMOTUZUMAB,8387.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NIMOTUZUMAB</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain</title>
			<link>http://www.lifescience-online.com/Labopharm_Announces_FDA_Approval_of_Once_Daily_RYZ,13592.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/labopharm,5993.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Labopharm Inc</u></font></a><br /><a href='http://www.lifescience-online.com/purdue_pharma_lp,6179.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PURDUE PHARMA LP</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/ONCE-DAILY_TRAMADOL,4635.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ONCE-DAILY TRAMADOL</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 29 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>SemBioSys Receives US$2.5 Million in Option Agreement with MannKind for Plant-produced Insulin</title>
			<link>http://www.lifescience-online.com/SemBioSys_Receives_US_2_5_Million_in_Option_Agreem,13550.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Metabolic Disease</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/mannkind,6062.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MANNKIND Corp</u></font></a><br /><a href='http://www.lifescience-online.com/sembiosys_genetics,7769.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SEMBIOSYS GENETICS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/INSULIN_INHALED_(RECOMBINANT_HUMAN_INSULIN),384.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>INSULIN INHALED (RECOMBINANT HUMAN INSULIN)</u></font></a><br /><a href='http://www.lifescience-online.com/RECOMBINANT_HUMAN_INSULIN,2638.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>RECOMBINANT HUMAN INSULIN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 23 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Generex Announces Governmental Approval of its Oral Insulin Spray Product in Lebanon</title>
			<link>http://www.lifescience-online.com/Generex_Announces_Governmental_Approval_of_its_Ora,13523.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Metabolic Disease</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/generex_biotechnology,678.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GENEREX BIOTECHNOLOGY CORP</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/ORAL_INSULIN,3118.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ORAL INSULIN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 22 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Paladin Labs Inc. (CC:PLB) Acquired ViRexx Medical Corp. (VIR.V)</title>
			<link>http://www.lifescience-online.com/Paladin_Labs_Inc___CC_PLB__Acquired_ViRexx_Medical,13518.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/3/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Changes and Acquisitions</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/virexx_medical,4955.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ViRexx Medical Corp</u></font></a><br /><a href='http://www.lifescience-online.com/paladin_labs,9008.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PALADIN LABS INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 22 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>NicOx SA (NCOX.F) Announces Results for TPI 1020 in COPD</title>
			<link>http://www.lifescience-online.com/NicOx_SA__NCOX_F__Announces_Results_for_TPI_1020_i,13530.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Respiratory System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/nicox_sa,6243.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Nicox SA</u></font></a><br /><a href='http://www.lifescience-online.com/topigen_pharmaceuticals,6872.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>TOPIGEN PHARMACEUTICALS INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 22 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>